Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Central Nervous System Neoplasms × motexafin gadolinium × Clear all

Phase

Phase 1 4 Phase 2 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 CNS 1

Conditions

Neurotoxicity Syndromes 1 Lymphoma 1 Central Nervous System Neoplasms 1

Interventions

motexafin gadolinium 1 irinotecan sucrosofate 1 bemcentinib 1 Vincristine 1 Temozolomide 1 Rituximab 1 Radiotherapy 1 Radiation 1 Procarbazine 1 Postoperative Period 1 Pemetrexed 1 Methotrexate 1 Memantine 1 Irinotecan 1 Donepezil 1 Cytarabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00734773 2012-05-18

Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL

Northwestern University

Phase EARLY_PHASE1 Withdrawn

Lymphoma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡